- Study Details: IMPACT -

Cell Therapy in Children Diagnosed with Autism

The Duke Marcus Center IMPACT Clinical Trial is testing a new cell therapy. This phase II randomized ("flip of a coin"), blinded, placebo-controlled clinical trial is testing whether cell therapy can help improve social and communication skills in children diagnosed with autism.

Children in huddle smiling down at camera


Pro#: 00102894

Criteria: Children 4-11 years of age with a diagnosis of autism. Other requirements apply, which will be discussed during screening for eligibility.

Enrollment status: Enrollment is closed. 

Date: May 15, 2020 - June 15, 2022

- Additional Study Team Members -

- Related Journal Articles -